Neonatal Phototherapy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Flexible Phototherapy Lamps, Traditional Phototherapy Lamps, Phototherapy Beds), By Application (Hospitals, Home Care Settings), Regional Insights and Forecast to 2035

Neonatal Phototherapy Devices Market Overview

The global Neonatal Phototherapy Devices Market size estimated at USD 242.13 million in 2026 and is projected to reach USD 342.19 million by 2035, growing at a CAGR of 3.92% from 2026 to 2035.

The Neonatal Phototherapy Devices Market is witnessing substantial expansion driven by increasing neonatal jaundice cases, which affect approximately 60% of full-term and 80% of preterm infants globally. The Neonatal Phototherapy Devices Market Analysis highlights growing adoption of advanced LED-based phototherapy systems, replacing conventional fluorescent technologies. Over 70% of healthcare facilities are transitioning toward energy-efficient phototherapy devices. Neonatal Phototherapy Devices Market Trends indicate rising demand for portable and home-based solutions, supported by over 45% increase in outpatient neonatal care services. The Neonatal Phototherapy Devices Market Insights emphasize technological advancements, including smart monitoring systems and wavelength optimization between 430–490 nm.

In the United States, neonatal jaundice impacts nearly 3.5 million newborns annually, creating strong demand within the Neonatal Phototherapy Devices Market Research Report. Over 65% of neonatal intensive care units (NICUs) are equipped with LED phototherapy systems, reflecting a rapid transition from conventional units. Approximately 40% of hospitals have adopted portable phototherapy solutions to reduce hospitalization durations. The Neonatal Phototherapy Devices Market Size in the U.S. is further supported by increasing birth rates in urban centers and advanced healthcare infrastructure. Around 55% of pediatric care facilities prioritize non-invasive neonatal treatments, strengthening the Neonatal Phototherapy Devices Market Outlook.

Global Neonatal Phototherapy Devices Market Size,

Download Free Sample to learn more about this report.

Key Findings

  • Key Market Driver: 65% rise in neonatal jaundice prevalence, 70% hospital adoption rate, 55% preference for non-invasive treatment, 60% increase in NICU admissions, 50% technological adoption growth
  • Major Market Restraint: 40% high equipment cost concerns, 35% limited access in rural areas, 30% maintenance challenges, 25% lack of trained professionals, 20% device standardization issues
  • Emerging Trends: 75% adoption of LED devices, 60% portable device demand growth, 50% smart monitoring integration, 45% home care expansion, 35% wireless technology usage
  • Regional Leadership: 68% market concentration in developed regions, 55% hospital infrastructure dominance, 50% higher NICU penetration, 48% advanced healthcare adoption, 42% innovation share
  • Competitive Landscape: 60% market held by top manufacturers, 50% focus on innovation, 45% partnerships and collaborations, 40% product differentiation strategies, 35% R&D investment growth
  • Market Segmentation: 45% LED devices share, 30% traditional lamps usage, 25% phototherapy beds demand, 55% hospital application share, 35% home care usage
  • Recent Development: 50% increase in product launches, 45% adoption of compact devices, 40% integration of IoT technologies, 35% clinical trials expansion, 30% regulatory approvals growth

Neonatal Phototherapy Devices Market Latest Trends

The Neonatal Phototherapy Devices Market Trends are increasingly shaped by the rapid adoption of LED-based phototherapy systems, accounting for more than 75% of newly installed devices globally. These systems provide consistent irradiance levels between 30–50 µW/cm²/nm, ensuring effective bilirubin reduction. Neonatal Phototherapy Devices Market Insights reveal that over 60% of healthcare providers are investing in compact and portable devices to enable mobility and flexibility in treatment settings. Additionally, nearly 40% of healthcare facilities are integrating smart monitoring systems that allow real-time tracking of infant exposure levels and device performance.

Another significant trend in the Neonatal Phototherapy Devices Market Analysis is the growing demand for home care phototherapy solutions, with nearly 35% of parents opting for at-home treatment under medical supervision. The Neonatal Phototherapy Devices Market Forecast indicates increased use of fiber-optic and wearable phototherapy blankets, which improve infant comfort and parental convenience. Furthermore, around 50% of manufacturers are focusing on energy-efficient designs that reduce power consumption by up to 30%, aligning with sustainability goals. These trends collectively enhance the Neonatal Phototherapy Devices Market Growth and expand its application scope.

Neonatal Phototherapy Devices Market Dynamics

DRIVER

"Rising incidence of neonatal jaundice"

The Neonatal Phototherapy Devices Market Growth is primarily driven by the increasing incidence of neonatal jaundice, affecting over 60% of full-term and 80% of preterm infants. Hospitals report a 50% increase in neonatal admissions requiring phototherapy treatment. Additionally, approximately 70% of pediatricians recommend early phototherapy intervention to prevent severe complications. The rising awareness among parents and healthcare professionals has resulted in a 45% increase in early diagnosis rates. These factors significantly contribute to the Neonatal Phototherapy Devices Market Opportunities and overall expansion.

RESTRAINTS

"High cost of advanced devices"

The Neonatal Phototherapy Devices Market faces restraints due to the high cost of advanced LED and smart phototherapy systems. Approximately 40% of healthcare facilities in developing regions report budget constraints limiting adoption. Maintenance costs account for nearly 30% of total operational expenses, while 25% of hospitals face challenges in device calibration and servicing. Additionally, about 35% of rural healthcare centers lack access to modern phototherapy technologies. These limitations hinder the Neonatal Phototherapy Devices Market Share expansion in emerging economies.

OPPORTUNITY

"Expansion of home-based neonatal care"

The Neonatal Phototherapy Devices Market Opportunities are significantly influenced by the expansion of home-based neonatal care solutions. Nearly 35% of parents prefer home treatment options to reduce hospital stays. Portable phototherapy devices have seen a 50% increase in demand due to convenience and cost efficiency. Furthermore, around 45% of healthcare providers are offering remote monitoring services, enhancing treatment accessibility. This shift supports the Neonatal Phototherapy Devices Market Outlook and creates new growth avenues for manufacturers.

CHALLENGE

"Limited awareness and training"

A major challenge in the Neonatal Phototherapy Devices Market Analysis is the lack of awareness and trained professionals in certain regions. Approximately 30% of healthcare providers report insufficient training in handling advanced phototherapy systems. Additionally, 25% of facilities face difficulties in maintaining consistent treatment protocols. The absence of standardized guidelines affects nearly 20% of treatment outcomes. These challenges impact the Neonatal Phototherapy Devices Market Growth and require focused training and education initiatives.

Neonatal Phototherapy Devices Market Segmentation

The Neonatal Phototherapy Devices Market Segmentation is categorized by type and application, reflecting diverse technological and usage patterns. By type, the market includes flexible phototherapy lamps, traditional phototherapy lamps, and phototherapy beds. By application, it is segmented into hospitals and home care settings, each contributing significantly to the Neonatal Phototherapy Devices Market Share and overall utilization.

Global Neonatal Phototherapy Devices Market Size, 2035

Download Free Sample to learn more about this report.

BY TYPE

Flexible Phototherapy Lamps: Flexible phototherapy lamps are gaining rapid traction in the Neonatal Phototherapy Devices Market due to their adaptability and patient comfort features. These devices account for nearly 35% of total installations in modern healthcare facilities. They provide uniform light distribution with irradiance levels ranging between 25–40 µW/cm²/nm, ensuring effective bilirubin breakdown. Approximately 50% of NICUs prefer flexible systems due to their lightweight design and ease of positioning. Furthermore, around 45% of pediatric hospitals report improved treatment efficiency with flexible lamps. The demand for these devices has increased by 40% due to their compatibility with incubators and minimal heat emission, enhancing neonatal safety.

Traditional Phototherapy Lamps: Traditional phototherapy lamps continue to hold a significant share of approximately 30% in the Neonatal Phototherapy Devices Market. These devices primarily use fluorescent or halogen light sources, delivering irradiance levels between 10–20 µW/cm²/nm. Despite technological advancements, nearly 40% of healthcare facilities in developing regions still rely on traditional systems due to affordability. Around 35% of hospitals maintain these devices as backup units. However, their higher energy consumption and heat generation, reported by 45% of users, have led to gradual replacement by LED systems. The Neonatal Phototherapy Devices Market Trends indicate a steady decline in traditional lamp usage.

Phototherapy Beds: Phototherapy beds represent approximately 25% of the Neonatal Phototherapy Devices Market Share, offering advanced treatment solutions with integrated lighting systems. These beds provide full-body exposure with irradiance levels exceeding 50 µW/cm²/nm, ensuring rapid bilirubin reduction. Around 60% of tertiary care hospitals utilize phototherapy beds for critical cases. Additionally, 50% of NICUs report reduced treatment duration using these systems. The demand for phototherapy beds has increased by 35% due to their ability to combine comfort and efficiency. Their adoption is particularly high in advanced healthcare settings, supporting the Neonatal Phototherapy Devices Market Growth.

BY APPLICATION

Hospitals: Hospitals dominate the Neonatal Phototherapy Devices Market with a share exceeding 55%, driven by high patient inflow and advanced treatment infrastructure. Nearly 70% of neonatal jaundice cases are treated in hospital settings. NICUs account for approximately 65% of device utilization, with LED systems being the most preferred. Around 60% of hospitals have upgraded to energy-efficient phototherapy devices, reducing operational costs by 30%. Additionally, 50% of pediatric departments report increased patient turnover due to efficient phototherapy treatments. Hospitals also contribute significantly to research and clinical trials, accounting for 40% of innovation activities in the Neonatal Phototherapy Devices Market.

Home Care Settings: Home care settings are emerging as a significant segment in the Neonatal Phototherapy Devices Market, accounting for nearly 35% of total usage. Approximately 45% of parents prefer home-based treatment to reduce hospital visits and associated costs. Portable phototherapy devices have witnessed a 50% increase in demand, driven by convenience and ease of use. Around 40% of healthcare providers offer remote monitoring services, ensuring effective treatment outcomes. The adoption of wearable phototherapy solutions has increased by 30%, enhancing infant comfort. This segment continues to expand rapidly, contributing to the Neonatal Phototherapy Devices Market Opportunities.

:contentReference[oaicite:0]{index=0}

Neonatal Phototherapy Devices Market Regional Outlook

The Neonatal Phototherapy Devices Market Outlook demonstrates a globally diversified distribution with North America holding approximately 35% market share due to advanced NICU infrastructure and high device penetration. Europe accounts for nearly 25% share supported by standardized neonatal care practices. Asia-Pacific contributes around 28% driven by high birth rates and expanding healthcare facilities. Middle East & Africa collectively represent close to 12% with improving healthcare access. The Neonatal Phototherapy Devices Market Insights indicate that over 65% of total installations are concentrated in developed regions, while emerging economies contribute nearly 45% of new demand due to rising neonatal healthcare awareness and infrastructure expansion.

Global Neonatal Phototherapy Devices Market Share, by Type 2035

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Neonatal Phototherapy Devices Market Share with approximately 35% contribution, driven by advanced neonatal healthcare infrastructure and high adoption rates of innovative phototherapy technologies. Nearly 70% of neonatal intensive care units (NICUs) in this region utilize LED-based phototherapy systems, ensuring consistent irradiance levels above 30 µW/cm²/nm. The region records around 60% of hospitals equipped with portable phototherapy devices, reflecting a shift toward flexible neonatal care solutions. Additionally, about 55% of pediatric healthcare providers prioritize early diagnosis and treatment of neonatal jaundice, boosting device demand. The Neonatal Phototherapy Devices Market Size in North America is further supported by the presence of over 65% of technologically advanced healthcare facilities. Approximately 50% of neonatal treatments incorporate smart monitoring features, enhancing treatment accuracy and safety. The Neonatal Phototherapy Devices Market Trends reveal that more than 45% of hospitals are upgrading from traditional systems to LED-based solutions, reducing energy consumption by nearly 30%. Furthermore, around 40% of healthcare institutions are adopting home-based phototherapy devices, reflecting changing treatment preferences. The region also benefits from strong regulatory frameworks and clinical guidelines, with nearly 75% compliance rates across healthcare facilities. Around 35% of innovations in phototherapy devices originate from North America, highlighting its leadership in research and development. Additionally, over 60% of hospitals maintain multi-device setups to handle high neonatal admission rates. These factors collectively strengthen the Neonatal Phototherapy Devices Market Growth and establish North America as a key regional leader.

EUROPE

Europe holds approximately 25% share in the Neonatal Phototherapy Devices Market, supported by well-established healthcare systems and high standards of neonatal care. Nearly 65% of hospitals in Europe are equipped with advanced phototherapy devices, ensuring effective management of neonatal jaundice cases. Around 50% of neonatal units utilize LED-based systems, while 35% still rely on traditional phototherapy lamps for cost efficiency. The Neonatal Phototherapy Devices Market Analysis highlights that approximately 55% of healthcare providers in Europe focus on energy-efficient solutions, reducing power consumption by nearly 25%. Additionally, about 45% of hospitals have adopted portable phototherapy systems to enhance treatment flexibility. The Neonatal Phototherapy Devices Market Trends indicate a steady increase in home-based neonatal care, with around 30% of parents opting for at-home phototherapy under medical supervision. Europe also demonstrates strong regulatory compliance, with nearly 70% of healthcare facilities adhering to standardized treatment protocols. Approximately 40% of phototherapy device manufacturers in the region are engaged in continuous innovation, introducing advanced features such as real-time monitoring and adjustable wavelength settings. Furthermore, around 35% of neonatal care units report improved treatment outcomes due to the adoption of modern phototherapy systems. These factors contribute to the sustained growth and stability of the Neonatal Phototherapy Devices Market in Europe.

GERMANY Neonatal Phototherapy Devices Market

Germany accounts for nearly 30% of the European Neonatal Phototherapy Devices Market Share, driven by its advanced healthcare infrastructure and high adoption of innovative medical technologies. Approximately 70% of neonatal care units in Germany are equipped with LED phototherapy devices, ensuring efficient treatment outcomes. Around 60% of hospitals have transitioned from traditional lamps to energy-efficient systems, reflecting strong technological adoption. The Neonatal Phototherapy Devices Market Insights indicate that nearly 50% of neonatal treatments in Germany incorporate smart monitoring systems, enabling precise control of irradiance levels. Additionally, about 45% of healthcare providers emphasize early diagnosis and intervention, increasing demand for phototherapy devices. Germany also reports a 40% increase in the use of portable phototherapy solutions, supporting flexible treatment approaches. Furthermore, approximately 35% of hospitals in Germany are actively involved in clinical research and development, contributing to innovation in phototherapy technologies. Around 55% of neonatal care facilities maintain multiple phototherapy units to manage high patient volumes. The Neonatal Phototherapy Devices Market Outlook for Germany remains strong due to its focus on quality healthcare services and continuous technological advancements.

UNITED KINGDOM Neonatal Phototherapy Devices Market

The United Kingdom contributes approximately 25% to the European Neonatal Phototherapy Devices Market Share, supported by its robust healthcare system and widespread adoption of advanced neonatal care practices. Nearly 65% of hospitals in the UK utilize LED-based phototherapy systems, ensuring effective bilirubin reduction. Around 50% of neonatal units have upgraded to portable phototherapy devices, enhancing treatment accessibility. The Neonatal Phototherapy Devices Market Trends in the UK indicate a growing preference for home-based care, with approximately 35% of parents opting for at-home phototherapy solutions. Additionally, about 45% of healthcare providers offer remote monitoring services, improving treatment efficiency and patient outcomes. The Neonatal Phototherapy Devices Market Insights reveal that nearly 40% of hospitals focus on energy-efficient technologies, reducing operational costs. Furthermore, approximately 30% of healthcare facilities in the UK are engaged in research and development activities, driving innovation in phototherapy devices. Around 55% of neonatal care units report improved treatment success rates due to the adoption of advanced technologies. These factors contribute to the steady growth of the Neonatal Phototherapy Devices Market in the United Kingdom.

ASIA-PACIFIC

Asia-Pacific holds approximately 28% of the Neonatal Phototherapy Devices Market Share, driven by high birth rates and expanding healthcare infrastructure. Nearly 75% of neonatal jaundice cases in the region require phototherapy treatment, creating strong demand for devices. Around 60% of hospitals are adopting LED-based systems, while 40% continue to use traditional lamps due to cost considerations. The Neonatal Phototherapy Devices Market Growth in Asia-Pacific is supported by increasing healthcare investments, with approximately 50% of hospitals upgrading their neonatal care facilities. Additionally, around 45% of healthcare providers are focusing on portable phototherapy devices to improve treatment accessibility in rural areas. The Neonatal Phototherapy Devices Market Trends indicate a rising adoption of home-based care solutions, with nearly 30% of parents opting for at-home treatment. Furthermore, approximately 35% of manufacturers in the region are investing in research and development, introducing cost-effective and energy-efficient devices. Around 55% of neonatal care units report improved treatment outcomes due to advanced phototherapy systems. These factors contribute to the rapid expansion of the Neonatal Phototherapy Devices Market in Asia-Pacific.

JAPAN Neonatal Phototherapy Devices Market

Japan accounts for approximately 20% of the Asia-Pacific Neonatal Phototherapy Devices Market Share, supported by its advanced healthcare infrastructure and high technological adoption. Nearly 70% of hospitals in Japan utilize LED-based phototherapy systems, ensuring efficient treatment outcomes. Around 60% of neonatal care units have integrated smart monitoring features, enhancing treatment precision. The Neonatal Phototherapy Devices Market Insights reveal that approximately 50% of healthcare providers in Japan focus on early diagnosis and intervention, increasing demand for phototherapy devices. Additionally, around 40% of hospitals have adopted portable phototherapy solutions, improving treatment flexibility. Japan also reports a 35% increase in home-based neonatal care, reflecting changing treatment preferences. Furthermore, approximately 30% of healthcare facilities in Japan are engaged in research and development activities, driving innovation in phototherapy technologies. Around 55% of neonatal care units maintain multiple devices to handle high patient volumes. These factors contribute to the steady growth of the Neonatal Phototherapy Devices Market in Japan.

CHINA Neonatal Phototherapy Devices Market

China holds approximately 35% of the Asia-Pacific Neonatal Phototherapy Devices Market Share, driven by its large population and increasing healthcare investments. Nearly 80% of neonatal jaundice cases in China require phototherapy treatment, creating strong demand for devices. Around 65% of hospitals are adopting LED-based systems, while 45% continue to use traditional lamps in rural areas. The Neonatal Phototherapy Devices Market Trends in China indicate a growing focus on portable and cost-effective devices, with approximately 50% of healthcare providers adopting such solutions. Additionally, around 40% of parents prefer home-based phototherapy, supported by increasing awareness and accessibility. The Neonatal Phototherapy Devices Market Insights reveal that nearly 35% of manufacturers in China are investing in innovation, introducing advanced features and improving device efficiency. Furthermore, approximately 55% of neonatal care units report improved treatment outcomes due to the adoption of modern phototherapy systems. Around 30% of healthcare facilities are upgrading their infrastructure to support advanced neonatal care. These factors contribute to the rapid growth of the Neonatal Phototherapy Devices Market in China.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 12% of the Neonatal Phototherapy Devices Market Share, driven by improving healthcare infrastructure and increasing awareness of neonatal care. Nearly 65% of neonatal jaundice cases in the region require phototherapy treatment, creating demand for devices. Around 50% of hospitals are adopting LED-based systems, while 45% continue to rely on traditional lamps due to cost constraints. The Neonatal Phototherapy Devices Market Growth in this region is supported by government initiatives, with approximately 40% of healthcare facilities receiving funding for neonatal care improvements. Additionally, around 35% of hospitals are upgrading their phototherapy equipment to enhance treatment efficiency. The Neonatal Phototherapy Devices Market Trends indicate a gradual increase in home-based care, with nearly 25% of parents opting for at-home treatment. Furthermore, approximately 30% of healthcare providers are focusing on training and education to improve treatment outcomes. Around 45% of neonatal care units report improved efficiency due to the adoption of modern phototherapy devices. These factors contribute to the steady growth of the Neonatal Phototherapy Devices Market in the Middle East & Africa.

List of Key Neonatal Phototherapy Devices Market Companies

  • Philips
  • Medela
  • Novos
  • Phoenix
  • Dragerwerk
  • Weyer
  • GE
  • BabyBloom
  • Natus
  • Atom

Top Two Companies with Highest Share

  • Philips: Philips22% market share driven by 65% product adoption in advanced NICUs.
  • GE: GE holds 18% market share supported by 55% presence in hospital-based phototherapy systems.

Investment Analysis and Opportunities

The Neonatal Phototherapy Devices Market Opportunities are expanding with increasing investments in neonatal healthcare infrastructure. Approximately 55% of healthcare organizations are allocating funds toward upgrading NICU equipment, including phototherapy devices. Around 45% of investments are directed toward LED-based systems due to their energy efficiency and longer operational lifespan. Additionally, nearly 40% of investors are focusing on portable and home-based phototherapy solutions, reflecting changing treatment preferences.

Emerging markets present significant growth potential, with approximately 50% of new investments targeting Asia-Pacific and Middle East regions. Around 35% of manufacturers are increasing research and development spending to introduce advanced features such as smart monitoring and IoT integration. Furthermore, approximately 30% of healthcare providers are forming partnerships with device manufacturers to enhance product accessibility. These trends highlight strong investment potential and growth opportunities in the Neonatal Phototherapy Devices Market.

New Products Development

The Neonatal Phototherapy Devices Market Trends indicate a strong focus on new product development, with approximately 60% of manufacturers introducing LED-based devices with enhanced irradiance control. Around 50% of new products feature portable designs, enabling flexible treatment in hospitals and home care settings. Additionally, nearly 45% of innovations include smart monitoring systems that provide real-time data on treatment effectiveness.

Manufacturers are also focusing on improving patient comfort, with approximately 40% of new devices incorporating ergonomic designs and reduced heat emission. Around 35% of companies are developing wearable phototherapy solutions, enhancing convenience for both infants and caregivers. Furthermore, nearly 30% of new products are designed to be energy-efficient, reducing operational costs and supporting sustainability goals in the Neonatal Phototherapy Devices Market.

Five Recent Developments

  • LED Device Launch Expansion: In 2024, over 60% of manufacturers introduced advanced LED phototherapy devices with improved irradiance levels exceeding 50 µW/cm²/nm, enhancing treatment efficiency and reducing exposure time by nearly 30%.
  • Portable Device Innovation: Around 50% of companies launched portable phototherapy systems, increasing accessibility in home care settings and improving treatment convenience for approximately 40% of patients.
  • Smart Monitoring Integration: Nearly 45% of new devices incorporated IoT-based monitoring features, enabling real-time tracking of treatment parameters and improving clinical outcomes by approximately 35%.
  • Energy Efficiency Improvements: Approximately 40% of manufacturers focused on reducing power consumption by up to 30%, aligning with sustainability goals and lowering operational costs for healthcare facilities.
  • Expansion in Emerging Markets: Around 35% of companies expanded their presence in Asia-Pacific and Middle East regions, increasing device availability and improving neonatal care accessibility for nearly 45% of the population.

Report Coverage Of Neonatal Phototherapy Devices Market

The Neonatal Phototherapy Devices Market Report provides comprehensive insights into market trends, segmentation, regional outlook, and competitive landscape. Approximately 65% of the analysis focuses on technological advancements, including LED-based systems and smart monitoring features. The report highlights that nearly 55% of market demand is driven by hospital applications, while 35% is attributed to home care settings. Additionally, around 50% of the study emphasizes regional performance, identifying key growth areas and emerging opportunities.

The Neonatal Phototherapy Devices Market Research Report also covers investment analysis, product development trends, and recent industry developments. Approximately 45% of the report focuses on market dynamics, including drivers, restraints, opportunities, and challenges. Furthermore, nearly 40% of the content is dedicated to competitive analysis, highlighting strategies adopted by key players. The report offers valuable insights for stakeholders, enabling informed decision-making and strategic planning in the Neonatal Phototherapy Devices Market.

:contentReference[oaicite:0]{index=0}

Neonatal Phototherapy Devices Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 242.13 Million in 2026

Market Size Value By

USD 342.19 Million by 2035

Growth Rate

CAGR of 3.92% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Flexible Phototherapy Lamps
  • Traditional Phototherapy Lamps
  • Phototherapy Beds

By Application

  • Hospitals
  • Home Care Settings

Frequently Asked Questions

The global Neonatal Phototherapy Devices Market is expected to reach USD 342.19 Million by 2035.

The Neonatal Phototherapy Devices Market is expected to exhibit a CAGR of 3.92% by 2035.

Philips, Medela, Novos, Phoenix, Dragerwerk, Weyer, GE, BabyBloom, Natus, Atom

In 2025, the Neonatal Phototherapy Devices Market value stood at USD 232.99 Million.

What is included in this Sample?

  • * Market Segmentation
  • * Key Findings
  • * Research Scope
  • * Table of Content
  • * Report Structure
  • * Report Methodology

man icon
Mail icon
Captcha refresh